REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 98 filers reported holding REVANCE THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,237,000 | -19.2% | 45,800 | -58.6% | 0.19% | +38.5% |
| Q2 2022 | $1,530,000 | +155.4% | 110,690 | +491.4% | 0.14% | +743.8% |
| Q2 2015 | $599,000 | -26.3% | 18,718 | -55.5% | 0.02% | -23.8% |
| Q3 2014 | $813,000 | -33.2% | 42,070 | +17.5% | 0.02% | -34.4% |
| Q2 2014 | $1,217,000 | – | 35,804 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |